All treatments
Treatment
XELJANZ 10 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
(A)nalysis of immunological (VA)riables in ex vivo (T)ofacitinib-treated human biopsies from (A)ctive ulcerative colitis patients to predict clinical (R)esponse (the AVATAR study).
This study looks at how a medicine called Xeljanz (tofacitinib) affects cells from people with ulcerative colitis. Researchers want to understand if these early changes can help predict which patients will get better with this treatment.
For: Ulcerative colitisItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Investigator Initiated, descriptive, proof-of-concept, open-label pilot study targeting the tumor microenvironment and skin barrier deficiency through JAK1/3 inhibition
This study is testing a medicine called Xeljanz for a skin condition called Mycosis Fungoides. Doctors want to see if it helps improve the condition by checking how patients respond to the treatment.
For: Mycosis FungoidesDenmark